To find out the Effect of Yavachoorna potentiated in Gayatryadi kashaya as a Medicated diet in increased sugar level
Phase 3
- Conditions
- Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
- Registration Number
- CTRI/2023/07/055521
- Lead Sponsor
- SRUTHI M
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)having FBS value between 100-125mg%
2)having hba1c value between 5.7-6.4%
Exclusion Criteria
1)known cases of Type 2 diabetes
2)gestational diabetes
3)Patient under hypoglycemic drugs
4)known cases of endocrine disorders and thyroid problems
5)any known cases of Malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FBS <br/ ><br>HBA1CTimepoint: 0th <br/ ><br>90th
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Yavachoorna's glucose-lowering effects in prediabetes?
How does Yavachoorna-Gayatryadi kashaya compare to metformin in prediabetes glucose control?
Which biomarkers predict response to Yavachoorna-Gayatryadi kashaya in prediabetes patients?
What is the safety profile of Yavachoorna-Gayatryadi kashaya in prediabetes management?
Are there synergistic effects of Yavachoorna with other Ayurvedic compounds in metabolic syndrome treatment?